StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Leerink Reiterates Outperform Rating on Eli Lilly (LLY)
May 26, 2026 3:05 AM
Leerink analyst David Risinger reiterated an Outperform rating and $1,119.00 price target on Eli Lilly (NYSE: LLY)The analyst comments: “LLY ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
